All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • VBC108Phase 21 trial

    VelaVigo Bio Inc · Advanced Solid Tumors

  • VBC117Phase 21 trial

    VelaVigo Bio Inc · Advanced Solid Tumors

  • VCA-894APhase 21 trial

    Vanda Pharmaceuticals · Charcot Marie Tooth Disease (CMT), Neuromuscular Diseases (NMD)

  • VDMN-21Phase 21 trial

    Veradermics, Inc. · Verruca Vulgaris, Warts, Common Wart

  • Vebeglogene autotemcelBeta-globin lentiviral vector transduced autologous HSPCsPhase 21 trial

    Lantu Biopharma · Beta-Thalassemia

  • VEL-101Pegrizeprument, FR104Phase 21 trial

    Asahi Kasei Therapeutics, Inc. · Transplantation, Kidney

  • VERT-002PFL-002Phase 21 trial

    Pierre Fabre Medicament · Solid Tumor, MET Alteration

  • VERVE-102LY4636581Phase 21 trial

    Eli Lilly · Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia

  • VG712A-dmDT390-bisFv fusion protein, UCHT1Phase 21 trial

    Virogen Biotechnology Inc. · Mycosis Fungoides

  • VG801Phase 21 trial

    VeonGen Therapeutics GmbH · Retinal Dystrophy Due to Biallelic ABCA4 Mutations, Stargardt Disease 1

  • VH3810109Phase 21 trial

    GSK · HIV Infections

  • VH4011499Phase 21 trial

    GSK · HIV Infections

  • VH4524184Phase 21 trial

    GSK · HIV Infections

  • VI-0609Phase 21 trial

    VIVUS LLC · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma

  • VIB305Phase 21 trial

    Vibrant Sciences Limited · Advanced Solid Tumors

  • VipoglanstatPhase 21 trial

    Gesynta Pharma AB · Endometriosis

  • VIR-5818Phase 21 trial

    Vir Biotechnology, Inc. · Locally Advanced or Metastatic HER2-Expressing Cancers

  • VLS-1488Phase 21 trial

    Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer

  • VMD-102Single agentPhase 21 trial

    VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)

  • VMD-3866Phase 21 trial

    VM Therapeutics LLC · Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy

  • VMD-928Phase 21 trial

    VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer

  • VO659Phase 21 trial

    Vico Therapeutics B. V. · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease

  • vopimetostatPhase 21 trial

    Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC

  • VOY-101Phase 21 trial

    Perceive Biotherapeutics, Inc. · Age-Related Macular Degeneration, Geographic Atrophy, Non-neovascular AMD

  • VP-001Phase 21 trial

    PYC Therapeutics · Retinitis Pigmentosa 11, Retinal Degeneration, Retinal Disease

  • VP-16Phase 21 trial

    Sichuan Honghe Biotechnology Co., Ltd. · Recurrent Glioblastoma

  • VRN110755Phase 21 trial

    Voronoi, Inc · EGFR-Mutant Non-Small Cell Lung Cancer

  • VS-101Phase 21 trial

    VSPharmTech Co.,Ltd. · Head and Neck Cancer Squamous Cell Carcinoma

  • VSA006Phase 21 trial

    Visirna Therapeutics HK Limited · Nash

  • VSJ-110Phase 21 trial

    Vanda Pharmaceuticals · Dry Eye

  • VT7208Phase 21 trial

    Vidya Therapeutics Inc · Multiple Sclerosis

  • VTRU200Phase 21 trial

    Vitruviae · Acute Myeloid Leukemia, Diffuse Large B Cell Lymphoma (DLBCL), High Risk Myelodysplastic Syndrome

  • VTX2735LY5625574Phase 21 trial

    Zomagen Biosciences Ltd. · Recurrent Pericarditis

  • VUM02Phase 21 trial

    Wuhan Optics Valley Vcanbiopharma Co., Ltd. · Steroid-refractory Acute Graft-versus-host Disease

  • VV119Phase 21 trial

    Vigonvita Life Sciences · Schizophrenia

  • VV913Phase 21 trial

    Vigonvita Life Sciences · Premature Ejaculation

  • VVD-133214Phase 21 trial

    Vividion Therapeutics, Inc. · Colorectal Adenocarcinoma

  • VX-01Phase 21 trial

    Vantage Biosciences Ltd · Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy

  • VX-264Phase 21 trial

    Vertex Pharmaceuticals · Type 1 Diabetes

  • VX-407Phase 21 trial

    Vertex Pharmaceuticals · Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  • VY7523Phase 21 trial

    Voyager Therapeutics · Alzheimer's Disease (AD)

  • WAL0921Phase 21 trial

    Walden Biosciences · Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease

  • WAS123Phase 21 trial

    EMS · Schizophenia Disorder

  • WEF-001Phase 21 trial

    Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer

  • WJ22096Phase 21 trial

    Nanjing Jingao biomidical technology Co. Ltd. · Advanced Solid Tumors

  • WTX-330Phase 21 trial

    Werewolf Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma

  • WVE-006Phase 21 trial

    Wave Life Sciences USA, Inc. · Alpha-1 Antitrypsin Deficiency

  • WVE-007Phase 21 trial

    Wave Life Sciences USA, Inc. · Overweight and Obesity

  • WXSH0102Phase 21 trial

    Cisen Pharmaceutical CO., LTD. · Vaginitis

  • XC001Phase 21 trial

    XyloCor Therapeutics, Inc. · Coronary Artery Disease (CAD)

NewerPage 73 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.